Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -523,837 | -378,192 | -248,486 | -122,967 | -444,440 |
| Depreciation Amortization | 14,146 | 16,387 | 11,180 | 5,888 | 14,182 |
| Income taxes - deferred | -102 | N/A | N/A | N/A | -36 |
| Accounts receivable | 12,397 | 9,895 | 10,018 | 9,733 | 1,913 |
| Accounts payable and accrued liabilities | -11,690 | 1,247 | -2,101 | 779 | 2,382 |
| Other Working Capital | -22,974 | 28,758 | 32,470 | 17,751 | 16,748 |
| Other Operating Activity | 119,400 | 60,783 | 36,933 | 11,731 | 95,964 |
| Operating Cash Flow | $-412,660 | $-261,122 | $-159,986 | $-77,085 | $-313,287 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,989 | -9,093 | -6,157 | -2,876 | -7,258 |
| Purchase Of Investment | -960,689 | -816,049 | -527,887 | -295,314 | -987,533 |
| Sale Of Investment | 1,178,455 | 907,722 | 617,454 | 308,648 | 1,491,004 |
| Investing Cash Flow | $202,777 | $82,580 | $83,410 | $10,458 | $496,213 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -250,000 |
| Common Stock Issued | 33,238 | 31,436 | 28,523 | 17,106 | 23,396 |
| Other Financing Activity | 3,000 | 2,250 | 1,500 | 750 | 146,250 |
| Financing Cash Flow | $36,238 | $33,686 | $30,023 | $17,856 | $-80,354 |
| Exchange Rate Effect | -92 | -82 | -57 | -20 | 20 |
| Beginning Cash Position | 198,955 | 198,955 | 198,955 | 198,955 | 96,363 |
| End Cash Position | 25,218 | 54,017 | 152,345 | 150,164 | 198,955 |
| Net Cash Flow | $-173,737 | $-144,938 | $-46,610 | $-48,791 | $102,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -412,660 | -261,122 | -159,986 | -77,085 | -313,287 |
| Capital Expenditure | -14,989 | -9,093 | -6,157 | -2,876 | -7,258 |
| Free Cash Flow | -427,649 | -270,215 | -166,143 | -79,961 | -320,545 |